David Klonoff, M.D.
Investigator
Dr. David C. Klonoff is an internationally recognized endocrinologist and pioneer in diabetes technology. He serves as Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute at Mills-Peninsula Medical Center and is a Clinical Professor of Medicine at UCSF. Widely regarded as the founder of the diabetes technology field, he established the Diabetes Technology Meeting, the Hospital Diabetes Meeting, and the Diabetes Technology Society. Dr. Klonoff has authored more than 400 scientific publications and led over 130 clinical trials, including the first multicenter outpatient artificial pancreas study. His innovations include the Glycemia Risk Index and major cybersecurity standards for medical devices. His honors include the ADA Outstanding Physician Clinician Award, the FDA Director’s Special Citation, the IEEE Conformity Assessment Award, and recognition as a top 1% U.S. endocrinology researcher. A leader in global policy, digital health, and device safety, he continues to shape the future of diabetes care.
Clinical trials
- Clinical trial
Diabetes I or II Sensor GENESIS
GENESIS: next GENEration Sensor Life Study
Status: Open to Enrollment
- Clinical trial
Diabetes KOS Argus Continuing Glucose Monitoring System
Argus 2.0 Adoption Study
Status: Coming Soon
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Status: Open to Enrollment
- Clinical trial
Hypothyroidism M21-341 AVANTI
A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism
Status: Open to Enrollment
- Clinical trial
Type 1 Diabetes ONWARDS 11
A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Status: Open to Enrollment